These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38761898)

  • 1. Cu(II) binding to the λ6aJL2-R24G antibody light chain protein associated with light chain amyloidosis disease: The role of histidines.
    Pelaez-Aguilar AE; Mata-Salgado F; Morales-Ortiz A; Millán-Pacheco C; Olvera-Carranza C; Salgado-Delgado J; Pastor N; Rivillas-Acevedo L
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132393. PubMed ID: 38761898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-Specific Interactions with Copper Promote Amyloid Fibril Formation for λ6aJL2-R24G.
    Pelaez-Aguilar AE; Valdés-García G; French-Pacheco L; Pastor N; Amero C; Rivillas-Acevedo L
    ACS Omega; 2020 Apr; 5(13):7085-7095. PubMed ID: 32280849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.
    Pelaez-Aguilar AE; Rivillas-Acevedo L; French-Pacheco L; Valdes-Garcia G; Maya-Martinez R; Pastor N; Amero C
    Biochemistry; 2015 Aug; 54(32):4978-86. PubMed ID: 26214579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.
    Russo R; Romeo M; Schulte T; Maritan M; Oberti L; Barzago MM; Barbiroli A; Pappone C; Anastasia L; Palladini G; Diomede L; Ricagno S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Dynamics in 6aJL2 Proteins Associated with AL Amyloidosis, a Conformational Disease.
    Maya-Martinez R; French-Pacheco L; Valdés-García G; Pastor N; Amero C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driving forces in amyloidosis: How does a light chain make a heavy heart?
    Otzen DE
    J Biol Chem; 2021; 296():100785. PubMed ID: 34019874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis.
    Villanueva J; Hoshino M; Katou H; Kardos J; Hasegawa K; Naiki H; Goto Y
    Protein Sci; 2004 Mar; 13(3):797-809. PubMed ID: 14767076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational evidences of a misfolding event in an aggregation-prone light chain preceding the formation of the non-native pathogenic dimer.
    Desantis F; Miotto M; Milanetti E; Ruocco G; Di Rienzo L
    Proteins; 2024 Jul; 92(7):797-807. PubMed ID: 38314653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation of the constant domain drives amyloid formation by immunoglobulin light chains.
    Lavatelli F; Natalello A; Marchese L; Ami D; Corazza A; Raimondi S; Mimmi MC; Malinverni S; Mangione PP; Palmer MT; Lampis A; Concardi M; Verona G; Canetti D; Arbustini E; Bellotti V; Giorgetti S
    J Biol Chem; 2024 Apr; 300(4):107174. PubMed ID: 38499153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal stability threshold for amyloid formation in light chain amyloidosis.
    Poshusta TL; Katoh N; Gertz MA; Dispenzieri A; Ramirez-Alvarado M
    Int J Mol Sci; 2013 Nov; 14(11):22604-17. PubMed ID: 24248061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation?
    Rudiño-Piñera E; Peláez-Aguilar ÁE; Amero C; Díaz-Vilchis A
    Biochem Biophys Rep; 2019 Dec; 20():100682. PubMed ID: 31517067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin light chain amyloid aggregation.
    Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
    Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.
    Pradhan T; Annamalai K; Sarkar R; Huhn S; Hegenbart U; Schönland S; Fändrich M; Reif B
    J Biol Chem; 2020 Dec; 295(52):18474-18484. PubMed ID: 33093170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
    Berghaus N; Schreiner S; Poos AM; Raab MS; Goldschmidt H; Mai EK; Salwender HJ; Bernhard H; Thurner L; Müller-Tidow C; Weinhold N; Hegenbart U; Schönland SO; Huhn S
    FEBS J; 2023 Sep; 290(17):4256-4267. PubMed ID: 37097223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the sequence features determining amyloidosis in human antibody light chains.
    Rawat P; Prabakaran R; Kumar S; Gromiha MM
    Sci Rep; 2021 Jul; 11(1):13785. PubMed ID: 34215782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains.
    Davern S; Murphy CL; O'Neill H; Wall JS; Weiss DT; Solomon A
    Biochim Biophys Acta; 2011 Jan; 1812(1):32-40. PubMed ID: 20692337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfolding and Aggregation Pathways of Variable Domains from Immunoglobulin Light Chains.
    Meunier-Carmenate Y; Valdés-García G; Maya-Martinez R; French-Pacheco L; Fernández-Silva A; González-Onofre Y; Millan-Pacheco C; Pastor N; Amero C
    Biochemistry; 2023 Mar; 62(5):1000-1011. PubMed ID: 36802343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
    Andrich K; Hegenbart U; Kimmich C; Kedia N; Bergen HR; Schönland S; Wanker E; Bieschke J
    J Biol Chem; 2017 Feb; 292(6):2328-2344. PubMed ID: 28031465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
    Mazzini G; Ricagno S; Caminito S; Rognoni P; Milani P; Nuvolone M; Basset M; Foli A; Russo R; Merlini G; Palladini G; Lavatelli F
    FEBS J; 2022 Jan; 289(2):494-506. PubMed ID: 34482629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.